Goodbody Health Inc., formerly Sativa Wellness Group Inc., is a Canada-based wellness company. The Company operates both in wellness testing in the United Kingdom and as a vertically integrated cannabinoid (CBD) company that operates in the United Kingdom and the European Union. It operates under one segment: the sale of cannabinoid products and clinic and cannabinoid testing. The Company focuses on offering COVID and blood testing clinics, CBD extraction, wholesale bulk isolate and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs. It provides a local level network of approximately 140 clinics, providing over 30 blood and polymerase chain reaction (PCR) tests for at home or in clinic testing. The Company’s subsidiaries include Borganic, Olimax, Olimax RE, Sativa Wellness Group Poland, Sativa Group, Goodbody Botanicals and Phytovista Laboratories.
No company officers listed.
No insider trading activity.
Insider trading information report provided by Copyright © 2022. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.